JP2919971B2 - Method for coating a pharmaceutical tablet core with a coating material and apparatus for performing the method - Google Patents
Method for coating a pharmaceutical tablet core with a coating material and apparatus for performing the methodInfo
- Publication number
- JP2919971B2 JP2919971B2 JP4504620A JP50462092A JP2919971B2 JP 2919971 B2 JP2919971 B2 JP 2919971B2 JP 4504620 A JP4504620 A JP 4504620A JP 50462092 A JP50462092 A JP 50462092A JP 2919971 B2 JP2919971 B2 JP 2919971B2
- Authority
- JP
- Japan
- Prior art keywords
- core
- coating
- powder
- dry powder
- transport device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000576 coating method Methods 0.000 title claims abstract description 108
- 239000011248 coating agent Substances 0.000 title claims abstract description 102
- 238000000034 method Methods 0.000 title claims abstract description 62
- 239000000463 material Substances 0.000 title claims description 40
- 239000000843 powder Substances 0.000 claims abstract description 97
- 239000007888 film coating Substances 0.000 claims description 9
- 238000009501 film coating Methods 0.000 claims description 9
- 238000010924 continuous production Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- -1 polyalkyne Substances 0.000 claims description 6
- 238000002844 melting Methods 0.000 claims description 5
- 230000008018 melting Effects 0.000 claims description 5
- 239000007791 liquid phase Substances 0.000 claims description 4
- 229920000728 polyester Polymers 0.000 claims description 4
- 235000000346 sugar Nutrition 0.000 claims description 4
- 150000005846 sugar alcohols Chemical class 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 229920001610 polycaprolactone Polymers 0.000 claims description 3
- 239000004632 polycaprolactone Substances 0.000 claims description 3
- 238000011282 treatment Methods 0.000 claims description 3
- 239000000811 xylitol Substances 0.000 claims description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 3
- 229960002675 xylitol Drugs 0.000 claims description 3
- 235000010447 xylitol Nutrition 0.000 claims description 3
- 239000004952 Polyamide Substances 0.000 claims description 2
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 2
- 229920002647 polyamide Polymers 0.000 claims description 2
- 239000007790 solid phase Substances 0.000 claims description 2
- 238000009736 wetting Methods 0.000 claims description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 claims 1
- 230000004927 fusion Effects 0.000 claims 1
- 239000000758 substrate Substances 0.000 abstract description 31
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 239000003826 tablet Substances 0.000 description 54
- 239000007788 liquid Substances 0.000 description 11
- 239000003814 drug Substances 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 238000010923 batch production Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000009503 electrostatic coating Methods 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000002195 soluble material Substances 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 239000012777 electrically insulating material Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D1/00—Processes for applying liquids or other fluent materials
- B05D1/02—Processes for applying liquids or other fluent materials performed by spraying
- B05D1/04—Processes for applying liquids or other fluent materials performed by spraying involving the use of an electrostatic field
- B05D1/06—Applying particulate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B16/00—Spray booths
- B05B16/90—Spray booths comprising conveying means for moving objects or other work to be sprayed in and out of the booth, e.g. through the booth
- B05B16/95—Spray booths comprising conveying means for moving objects or other work to be sprayed in and out of the booth, e.g. through the booth the objects or other work to be sprayed lying on, or being held above the conveying means, i.e. not hanging from the conveying means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B5/00—Electrostatic spraying apparatus; Spraying apparatus with means for charging the spray electrically; Apparatus for spraying liquids or other fluent materials by other electric means
- B05B5/08—Plant for applying liquids or other fluent materials to objects
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B5/00—Electrostatic spraying apparatus; Spraying apparatus with means for charging the spray electrically; Apparatus for spraying liquids or other fluent materials by other electric means
- B05B5/08—Plant for applying liquids or other fluent materials to objects
- B05B5/087—Arrangements of electrodes, e.g. of charging, shielding, collecting electrodes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B5/00—Electrostatic spraying apparatus; Spraying apparatus with means for charging the spray electrically; Apparatus for spraying liquids or other fluent materials by other electric means
- B05B5/08—Plant for applying liquids or other fluent materials to objects
- B05B5/082—Plant for applying liquids or other fluent materials to objects characterised by means for supporting, holding or conveying the objects
- B05B5/084—Plant for applying liquids or other fluent materials to objects characterised by means for supporting, holding or conveying the objects the objects lying on, or being supported above conveying means, e.g. conveyor belts
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D2258/00—Small objects (e.g. screws)
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D3/00—Pretreatment of surfaces to which liquids or other fluent materials are to be applied; After-treatment of applied coatings, e.g. intermediate treating of an applied coating preparatory to subsequent applications of liquids or other fluent materials
- B05D3/02—Pretreatment of surfaces to which liquids or other fluent materials are to be applied; After-treatment of applied coatings, e.g. intermediate treating of an applied coating preparatory to subsequent applications of liquids or other fluent materials by baking
- B05D3/0254—After-treatment
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Materials For Medical Uses (AREA)
- Electrostatic Spraying Apparatus (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
Description
【発明の詳細な説明】 本発明は、医薬錠剤コアにコーティング材料をコーテ
ィングする方法とこの方法を実施するための装置に関す
る。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method of coating a pharmaceutical tablet core with a coating material and an apparatus for performing the method.
錠剤の静電コーティングに関する提案は少なくとも、
この30年ほどにわたって行われている。例えば英国特許
明細書GB−1075404(1967年公告)には、統合された高
圧グリッドを備える第一段階噴霧器の下方へ錠剤コアが
運ばれると各錠剤の片面に液体が噴霧され、コーティン
グが乾燥され、次いで、統合された高圧グリッドを備え
る第二段階噴霧器の下方へ、コーティングされたコアが
錠剤の他面を最も上にして運ばれ、次いでそのコーティ
ングが再び乾燥されるようにした、錠剤をコーティング
する装置が提案されている。At least the suggestions for electrostatic coating of tablets,
It has been around for about 30 years. For example, British Patent Specification GB-1075404 (published 1967) states that when a tablet core is conveyed below a first stage sprayer with an integrated high pressure grid, a liquid is sprayed on one side of each tablet and the coating is dried. The coated core was then transported down the second stage sprayer with an integrated high pressure grid, with the coated core carried the other side of the tablet up, and then the coating was dried again. An apparatus has been proposed.
液体や乾燥粉末を用い、静電気で錠剤コアをコーティ
ングする各種の論文提案がなされているが、少なくとも
医薬錠剤の場合、妥当な規模で商業的に応用されるべく
充分に成功したこと立証した静電コーティング方法また
は装置は、これまでのところ全く認知されていない。例
えば毎分5000錠剤の割合で医薬錠剤コアを連続的に生成
し得る回転錠剤プレスがあるが、次の錠剤コアのコーテ
ィングは、回転ドラム内で液体コーティングを施すこと
により、バッチ工程として最も通常的に行われる。Various papers have been proposed to electrostatically coat tablet cores using liquids or dry powders, but at least for pharmaceutical tablets, electrostatics have proven to be sufficiently successful for commercial application on a reasonable scale. No coating method or apparatus has been recognized so far. For example, there are rotary tablet presses that can continuously produce pharmaceutical tablet cores at a rate of 5000 tablets per minute, but the next tablet core coating is most commonly used as a batch process by applying a liquid coating in a rotating drum. Done in
医薬品をコーティングする商業的に実施可能な装置ま
たは方法を得るためには、各種の問題が克服されなけれ
ばならない。コーティング材料として乾燥粉末よりも液
体を使用する方が多くの点で容易であり、研究には双方
の選択が考慮されているが、作業員は液体の使用に賛成
している。若し乾燥粉末が使用されれば、基体に対する
コーティングの付着性を得ることが一層困難であり、粉
末が静電気を荷電された場合にも、それは、それ自体で
充分に電気を伝導するとは思われない。基体と粉末との
間に永続的な接着をもたらすためには、粉末が、例えば
溶融により、フィルムに変化しなければならないが、多
くの場合に有機物質を包含する医薬品の場合、損傷され
てはならない。更にまた均等なコーティングが必要であ
るが、粉末が静電気を荷電された場合にも、電気的に絶
縁性の医薬基体上に粉末の均等なコーティングを得るこ
とは極めて困難である。Various problems must be overcome in order to obtain a commercially viable device or method for coating pharmaceuticals. Using a liquid as a coating material is easier than a dry powder in many respects, and studies have considered both options, but workers agree with the use of a liquid. If a dry powder is used, it is more difficult to obtain the adhesion of the coating to the substrate, and even if the powder is charged electrostatically, it is believed that it conducts electricity by itself. Absent. In order to provide a permanent bond between the substrate and the powder, the powder must be converted to a film, for example, by melting, but in the case of pharmaceuticals, which often include organic substances, must be damaged. No. Furthermore, even coatings are required, but even when the powders are charged electrostatically, it is very difficult to obtain a uniform coating of the powder on an electrically insulating pharmaceutical substrate.
液体コーティングが用いられる場合、コーティングは
乾燥されなければならない。理論的には、若干の情況に
おいて、この種の乾燥を室温で行うこともできるが、例
えば錠剤を加熱するためにプロセスが遂行されるべき速
度の故に、商業的な実際面でそれは重要であり、また液
体コーティングに用いられる溶媒を蒸発させるに要する
エネルギの大きな入力の故に、それには経費がかかる。
液体コーティングの別の不利点は、使用できる液体、望
ましくは水、の中へ溶解または適当に分散し得ない材料
をコーティングするためにそれを使用できないことであ
る。If a liquid coating is used, the coating must be dried. Theoretically, in some circumstances, this type of drying can be performed at room temperature, but it is important in commercial practice, for example, because of the rate at which the process should be performed to heat the tablet. It is also expensive because of the large input of energy required to evaporate the solvent used in the liquid coating.
Another disadvantage of liquid coatings is that they cannot be used to coat materials that cannot be dissolved or properly dispersed in a usable liquid, desirably water.
本発明の目的は、医薬錠剤コア(以下の記載におい
て、「コア」は「基体」とも称する)をコーティングす
る改良された方法および装置を提供することにある。SUMMARY OF THE INVENTION It is an object of the present invention to provide an improved method and apparatus for coating a pharmaceutical tablet core (herein "core" is also referred to as "substrate").
本発明によれば、搬送装置上に医薬錠剤コアを給送す
る段階と、 前記コアが前記搬送装置上で搬送される時に通過する
領域にコーティング材料を供給する段階と、 前記コアを前記コーティング材料とは異なる電位に維
持して、前記コアを前記領域通って前記搬送装置上で搬
送し、それによって、前記コーティング材料が前記コア
の露出面に引き付けられて該露出面上にコーティングを
形成する段階と、 を含む医薬錠剤コアにコーティング材料をコーティン
グする方法において、 前記コーティング材料として乾燥粉末を使用し、ま
た、該乾燥粉末が前記コアの露出面に引き付けられて該
露出面上にコーティングを形成した後に、この乾燥粉末
が前記コアに固着された融着フィルムコーティングに転
化するように、この乾燥粉末を処理することを特徴とす
る方法が提供される。According to the present invention, a step of feeding a pharmaceutical tablet core onto a transport device; a step of supplying a coating material to an area where the core passes when transported on the transport device; Transporting the core through the region on the transport device while maintaining the potential at a different electrical potential, thereby attracting the coating material to an exposed surface of the core to form a coating on the exposed surface. A method of coating a coating material on a pharmaceutical tablet core comprising: using a dry powder as the coating material, wherein the dry powder is attracted to an exposed surface of the core to form a coating on the exposed surface. Later treating the dry powder so as to convert it to a fused film coating adhered to the core. Is provided.
荷電プロセス中、搬送装置上に基体を置くことによ
り、基体上への粉末の良好な展着が得られ得ることが見
いだされている。また、ほぼ一定の厚さのコーティング
を有することが最終錠剤にとって重要であるとしても、
粉末が融着フィルムへ転化されればそれ以上のレベリン
グが生起し得るので、分布の多少のむらは必ずしも重大
ではないことも見いだされている。従って本発明は、所
望の厚さのコーティングが基体の表面上へ均等に施され
ることを可能にする。コーティングの厚さは、一般に10
μmよりも大である。上記に定義された本発明は更に、
粉末を融着フィルムへ転化させるエネルギの入力を必要
とするが、必要なエネルギの量は、適当な溶媒に溶解さ
れたコーティング物質を含む液体コーティングが施され
且つコーティングの実施後溶媒を蒸発させなければなら
ない場合に必要とされるそれよりも可成り少なくて良
い。この方法により、溶媒の処理や処分、ならびにバッ
チ操作の必要性が取り除かれる。It has been found that placing the substrate on a transport device during the charging process can result in good spreading of the powder on the substrate. Also, although having a coating of nearly constant thickness is important for the final tablet,
It has also been found that some unevenness in the distribution is not necessarily critical, as further leveling can occur if the powder is converted to a fused film. Thus, the present invention allows a coating of a desired thickness to be evenly applied on the surface of a substrate. Coating thickness is generally 10
It is larger than μm. The invention as defined above further comprises:
It requires the input of energy to convert the powder into a fused film, but the amount of energy required is to apply a liquid coating containing the coating material dissolved in a suitable solvent and to evaporate the solvent after the application of the coating. It may be significantly less than that required when it must. This method eliminates the need for solvent processing and disposal, as well as batch operations.
医薬品は通常、医薬錠剤(「錠剤」は後段に定義され
る通りである)であるが、これらはまた、経口により投
与されない移植片であっても良い。「錠剤」に対する明
細事項全体にわたり言及がなされ、本発明は、在来の形
状の医薬錠剤に対する特定の応用であるが、この用語
は、例えばペレット剤、カプセル剤または球状体も包含
する如く、広義に解釈されるべきであることを理解すべ
きである。The pharmaceuticals are usually pharmaceutical tablets ("tablets" are defined below), but they may also be implants that are not administered orally. Reference is made throughout the specification to "tablets" and the invention is of particular application to pharmaceutical tablets of conventional shape, but the term is broadly defined to include, for example, pellets, capsules or spheroids. It should be understood that
本発明の方法は一般に、プレス内で形成されて以来い
かなるコーティングも受けていない錠剤コア(または医
薬品の基体)のコーティングに利用されるが、既にコー
ティングされ若しくは部分的にコーティングされた錠剤
コアの上にコーティングを施すためにそれを用いること
もできる。The method of the present invention is generally used to coat tablet cores (or pharmaceutical substrates) that have not been subjected to any coating since they were formed in a press, but over coated or partially coated tablet cores. It can also be used to apply a coating to a coating.
本発明の方法は、連続プロセスとして実施することも
できる。実際上、コーティング・プロセスをバッチ・プ
ロセスとしてではなく連続的に操作し得ることは、可成
りの利点である。片側のみに、またはコーティングに少
なくとも一つの不連続性を伴って医薬基体をコーティン
グすることが望ましい、後で言及する若干の用途もある
が、一般的には錠剤コアの外面の全てをコーティングす
ることが望ましい。従ってこの方法には、望ましくは、
前記搬送段階において前記搬送装置に接触されていた前
記コアの面を露出させ且つ前記コアの融着フィルムコー
ティングを搬送装置に接触させて、当該搬送装置上に錠
剤コアを給送する段階と、 前記コアに被覆される乾燥粉末を当該搬送装置が通過
する領域に供給する段階と 当該搬送装置又は前記コア、或いはそれら双方を前記
乾燥粉末とは異なった電位に維持して、前記コアを当該
領域を通って当該搬送装置上で搬送し、それによって、
前記乾燥粉末が前記コアの露出された面に引き付けられ
るようにする段階と、 新しく引き付けられた粉末が前記コアに固着された融
着フィルムコーティングに転化するように、この乾燥粉
末コーティングを処理する段階とが、更に後続する段階
として含まれる。The method of the present invention can also be performed as a continuous process. In fact, it is a considerable advantage that the coating process can be operated continuously rather than as a batch process. It is desirable to coat the pharmaceutical substrate on one side only or with at least one discontinuity in the coating, although there are some applications mentioned below, but generally coating all of the outer surface of the tablet core Is desirable. Therefore, this method preferably
Exposing the surface of the core that has been in contact with the transfer device in the transfer step and contacting the fused film coating of the core with the transfer device to feed a tablet core onto the transfer device; Supplying the dry powder to be coated on the core to an area through which the transport device passes, and maintaining the transport device and / or the core, or both at a different potential from the dry powder, and moving the core through the area. And transported on said transport device, thereby
Allowing the dry powder to be attracted to the exposed surface of the core; and treating the dry powder coating to convert the newly attracted powder to a fused film coating affixed to the core. Are included as further subsequent steps.
実際面での便宜上、第二コーティング段階中に使用さ
れる搬送装置は第一コーティング段階中に使用されるも
のでないことが望ましいが、双方のコーティング段階に
同じ搬送装置を用いることは可能である。各コーティン
グ段階中に付与される粉末は通常は同じであるが、言う
までもなく、各段階に異なる粉末を付与することは可能
であり、同様に、通常は各段階で同じコーティングの厚
が付与されるが、望むならば、種々の厚さを付与するこ
とができる。For practical convenience, it is preferred that the transport device used during the second coating stage is not the one used during the first coating stage, but it is possible to use the same transport device for both coating stages. The powder applied during each coating stage is usually the same, but it goes without saying that it is possible to apply a different powder to each stage, as well as usually the same coating thickness at each stage However, various thicknesses can be applied if desired.
望むならば、医薬品の諸面がコーティングされていな
ければ、例えばそれらの諸面に粉末を付与すべく、更に
それ以上のコーティング段階を使用することもできる。If desired, further coating steps can be used, for example, to apply powders to the sides of the medicament if they are uncoated.
搬送装置は、なるべくなら、コンベヤ・ベルトを含む
ことが望ましい。しかし搬送装置は、基体が沿って滑る
傾斜静止面または振動面を含むことがある。基体と傾斜
面との間の摩擦は、裏側から傾斜面へ空気を通過させる
ことにより、低減することができる。Preferably, the transport device comprises a conveyor belt. However, the transport device may include an inclined stationary or vibrating surface along which the substrate slides. Friction between the substrate and the ramp can be reduced by passing air from the back side to the ramp.
粉末を融着フィルムへ転化させる段階は、都合良く、
粉末を液相に転化させた後、それが固相に戻る段階を含
むことができる。The step of converting the powder into a fused film is conveniently
After the powder has been converted to the liquid phase, it can include the step of returning to the solid phase.
本出願人等は、乾燥粉末の融着フィルムへの転化が、
コーティングを基体へ固着させるのに役立つのみなら
ず、それにより、基体上へのコーティング材料の配分を
更に均等にさせ得る装置も得られることを見いだした。
ある場合には、溶融された際、コーティングそれ自体が
基体へ均等に分布する程に低い粘度をコーティング材料
が有することもあるが、多くの場合、コーティング材料
はより粘性があり、従ってこの方法には、望ましくは、
基体の表面上のコーティングの深さを均等にするため
の、コーティングの更にそのほかの機械的処理が包含さ
れる。均等化段階は、振動プレートまたは回転ローラの
下に基体を通過させることによって行うことができ、こ
のプレートまたはローラは基体上のコーティングに接触
し且つそれを均等化する。あるいはまた均等化段階は、
空気の噴流、例えばエアナイフ、の下に基体を通過させ
ることによって行うことができ、エアナイフとして生成
された空気のカーテンが基体上のコーティングを均等化
するが、コーティングの過早な固化を回避するため、空
気を加熱することもできる。Applicants have reported that the conversion of the dry powder to a fused film
It has been found that not only does it help to adhere the coating to the substrate, but it also provides an apparatus that allows a more even distribution of the coating material on the substrate.
In some cases, when melted, the coating material has a viscosity low enough to distribute the coating itself to the substrate evenly, but in many cases, the coating material is more viscous, and thus, Preferably
Still other mechanical treatments of the coating are included to equalize the depth of the coating on the surface of the substrate. The equalization step can be performed by passing the substrate under a vibrating plate or rotating roller, which contacts or equalizes the coating on the substrate. Alternatively, the equalization step
This can be done by passing the substrate under a jet of air, e.g. an air knife, where an air curtain created as an air knife equalizes the coating on the substrate, but avoids premature solidification of the coating. The air can also be heated.
乾燥粉末は、望ましくは赤外線放射による加熱によ
り、望ましくは融着フィルムへ転化されるが、他の形式
の電磁放射線を用いても良い。融着フィルムへの転化も
また、その領域の圧力を低減させることにより、ある程
度または全面的に達成できる。通常、コーティングの変
化は、加熱に際しては粉末から液体への、また次いで冷
却に際しては連続的な固形コーティングへの、単に物理
的な変化であるが、その他の可能性もあり、例えば粉末
コーティングが、連続架橋重合体のコーティングを形成
すべく、例えばガンマ、紫外線または無線周波数帯域の
エネルギを以てする照射により処理段階中に硬化される
重合体を含むこともできる。The dry powder is preferably converted to a fused film, preferably by heating with infrared radiation, although other types of electromagnetic radiation may be used. Conversion to a fused film can also be achieved to some extent or all by reducing the pressure in that area. Usually, the change in coating is merely a physical change from a powder to a liquid on heating and then a continuous solid coating on cooling, but there are other possibilities as well, for example, where a powder coating is It may also include a polymer that is cured during the process step by irradiation with energy, for example, gamma, ultraviolet or radio frequency bands, to form a coating of a continuously crosslinked polymer.
粉末を、正でも負でも良い適正な電位に荷電させるこ
とが望ましい。粉末は、搬送装置が通過する領域へそれ
が供給される際に荷電されることが望ましい。荷電はコ
ロナ荷電装置を用いて行うこともできるが、別の可能性
は、摩擦電気で粉末に荷電させることである。普通、粉
末のそれと同じ符号の選定された電位(即ち粉末が正に
荷電されていれば正の電位、また粉末が負に荷電されて
いれば負の電位)に維持された1組以上の電極が、望ま
しくは、搬送装置上方の、粉末が供給される領域に設け
られる。電極の位置調整およびそれらが維持される単一
若しくは複数の電位は、領域、従って領域を通る粉末の
経路における電界に影響を及ぼす。It is desirable to charge the powder to an appropriate potential, which can be positive or negative. Desirably, the powder is charged as it is supplied to the area through which the transport device passes. Charging can also be performed using a corona charging device, but another possibility is to triboelectrically charge the powder. Usually, one or more pairs of electrodes maintained at a selected potential of the same sign as that of the powder (ie, a positive potential if the powder is positively charged, and a negative potential if the powder is negatively charged). However, desirably, it is provided in an area above the conveying device where the powder is supplied. The positioning of the electrodes and the potential or potentials at which they are maintained will affect the electric field in the region and thus the path of the powder through the region.
搬送装置は、望ましくは、地電位または粉末が荷電さ
れる電位と逆符号のそれの何れかの電位に維持される。
搬送装置は、医薬基体が載る導電性の上面を備えること
もできる。多くの場合、基体は、電気的に絶縁性の材料
で作られるが、それらは、例えば基体の外面を湿らせる
ことにより更に導電性となすべく、粉末の付与に先立っ
て処理することもできる。この種の加湿は地電位におけ
る基体の外面の保守を容易にさせ、従ってコアに対する
粉末の付与を容易にさせる。The transport device is desirably maintained at either ground potential or the potential opposite to that at which the powder is charged.
The delivery device may also have a conductive top surface on which the medicament substrate rests. In many cases, the substrates are made of an electrically insulating material, but they can also be treated prior to application of the powder to make them more conductive, for example by wetting the outer surface of the substrate. This type of humidification facilitates maintenance of the outer surface of the substrate at ground potential, and thus facilitates application of the powder to the core.
本発明の方法は、何れかの特定形式のコーティング材
料の利用に限定されてはいない。他方、良い結果を得る
ためには、乾燥粉末が次の物理的諸性質を有することが
望ましい。The method of the present invention is not limited to the use of any particular type of coating material. On the other hand, in order to obtain good results, it is desirable that the dry powder has the following physical properties.
(1) 1μmから1000μmの範囲、望ましくは30μm
から80μmの範囲の粒径。小さい粒径は、粉末に、それ
が供給され且つコンベヤ・ベルトが通過する領域内へ均
等に分散されることを可能にさせる。(1) 1 μm to 1000 μm, preferably 30 μm
Particle size in the range from to 80 μm. The small particle size allows the powder to be fed and distributed evenly into the area where the conveyor belt passes.
(2) 106Ωmから1024Ωmの範囲、望ましくは1010
Ωmから1014Ωmの範囲の比較的に高い抵抗率。高い抵
抗率は粉末荷電の維持を容易にさせるが、粉末に荷電さ
せることを一層困難にさせる。(2) In the range of 10 6 Ωm to 10 24 Ωm, preferably 10 10 Ωm
Relatively high resistivity in the range Ωm to 10 14 Ωm. High resistivity makes it easier to maintain the powder charge, but makes it more difficult to charge the powder.
(3) 液相における場合の、500Pas未満、望ましくは
75Pas未満の粘度。低い粘度は、錠剤コアの表面上のコ
ーティングの均等な広がりを容易にさせる。(3) Less than 500 Pas, preferably in the liquid phase
Viscosity less than 75 Pas. The low viscosity facilitates even spreading of the coating on the surface of the tablet core.
(4) 融着フィルムへの転化後の、0.5N/m2を超え
る、望ましくは3.5N/m2を超える引張強さ。次の、錠剤
の投与に至るまでの処理中に錠剤を防護するためには、
適度に強力且つ強じんなコーティングが必要である。(4) After conversion to fused film, greater than 0.5 N / m 2, preferably a tensile strength greater than 3.5 N / m 2. To protect the tablet during the next processing up to the administration of the tablet,
A moderately strong and tough coating is required.
(5) 50℃から180℃の範囲、望ましくは60℃から100
℃の範囲にある融点。比較的に低い融点の場合には、粉
末を液相へ転化させるのに、より少ないエネルギしか必
要とせず、加熱による錠剤に対する損傷の危険性が低減
される。後者の点は、錠剤コア内の薬剤が、その温度が
室温以上に可成り上昇すると損傷を受け易い場合、特に
重要である。(5) 50 ° C to 180 ° C, preferably 60 ° C to 100 ° C
Melting point in the range of ° C. With a relatively low melting point, less energy is required to convert the powder into the liquid phase, reducing the risk of damage to the tablet due to heating. The latter point is particularly important if the drug in the tablet core is susceptible to damage when its temperature rises significantly above room temperature.
単独で、または他の諸材料と配合されている時に、上
記に列挙された5項目の望ましい性質の若干または全て
に適合する材料の例を、ポリアミド、ポリアルキン、ワ
ックス、油、ポリエステル、糖アルコール、糖、ポリオ
キシエチレンおよびエチレン酢酸ビニル共重合体に見い
だすことができる。適当な糖アルコールの例は、ソルビ
トールおよびキシリトールである。適当な糖の例は、ス
クロースおよびラクトースである。本発明の方法に特に
適した性質を有するポリエステルはポリカプロラクトン
である。Examples of materials that, alone or when combined with other materials, meet some or all of the five desirable properties listed above include polyamides, polyalkynes, waxes, oils, polyesters, sugar alcohols, It can be found in sugar, polyoxyethylene and ethylene vinyl acetate copolymers. Examples of suitable sugar alcohols are sorbitol and xylitol. Examples of suitable sugars are sucrose and lactose. A polyester having properties particularly suitable for the method of the present invention is polycaprolactone.
上記に示した諸材料は、上記に示した諸性質に一層密
接に適合すべく、それらの物理的性質を向上させるた
め、他の諸材料をそれらと配合することにより変化させ
ることもできる。1種類以上の乳白剤、例えば二酸化チ
タンおよび/または着色剤、例えばアルミニウム・レー
キ若しくは染料、をコーティング材料の製剤に付与する
こともできる。The materials set forth above can also be varied by blending other materials with them to improve their physical properties to more closely match the properties set forth above. One or more opacifiers, such as titanium dioxide and / or colorants, such as aluminum lakes or dyes, can also be provided in the formulation of the coating material.
上記に列挙された材料は二つの種類、即ち水溶性材料
(ポリオキシエチレン、糖、アルコール)およびわずか
に水溶性若しくは不溶性の重合体材料に属する。コーテ
ィングが投薬に続いて急速に溶解する必要があれば水溶
性材料が一般的に望ましく、遅延され、制御され、また
は調整される薬剤の放出が必要であれば、わずかに水溶
性若しくは不溶性の重合体材料が恐らく有利である。The materials listed above belong to two classes: water-soluble materials (polyoxyethylene, sugars, alcohols) and slightly water-soluble or insoluble polymeric materials. A water-soluble material is generally desirable if the coating needs to dissolve rapidly following dosing, and a slightly water-soluble or insoluble heavy material if a delayed, controlled or regulated release of the drug is required. Coalescing materials are probably advantageous.
特に望ましい糖アルコールはキシリトールであり、特
に望ましい重合体材料は、例えばポリカプロラクトンの
ようなポリエステルである。但し双方の場合において、
材料の物理的性質を向上させるべく、少量の他の物質を
添加することが望ましい。A particularly preferred sugar alcohol is xylitol, and a particularly preferred polymeric material is a polyester such as, for example, polycaprolactone. However, in both cases,
It is desirable to add small amounts of other substances to improve the physical properties of the material.
本発明は、制御された厚さのコーティングを施すため
に用い、また、投与される際、即座に放出される、また
は制御され若しくは調整される放出の対象となる薬剤を
包有する医薬品に対して使用することができるが、この
種の制御または調整は、コーティングの特質に基づき且
つ/またはコアの特質に基づき達成される。所望の形式
の放出をコーティングの特性に基づき達成する場合に
は、製品の一部分をコーティングしないまま、または異
なる材料でコーティングしたままにして置くことが望ま
しい。円筒状の側壁で連結された両端部に両面を有する
錠剤の場合、コーティングされていない、または異なる
材料でコーティングされている部分は、錠剤の両面、両
面の一つの小部分、または錠剤の側壁、の一つであれば
良い。The present invention is used to apply controlled thickness coatings and to pharmaceuticals that contain a drug that is to be released immediately upon administration or to be controlled or regulated for release. Although it can be used, such control or regulation is achieved based on the properties of the coating and / or on the properties of the core. If the desired type of release is to be achieved based on the properties of the coating, it is desirable to leave a portion of the product uncoated or coated with a different material. In the case of a tablet having both sides at both ends connected by a cylindrical side wall, the uncoated or coated part with a different material may be the side of the tablet, one small part of both sides, or the side wall of the tablet, Anything is good.
既に明らかにされた如く、上述の諸方法は、それらを
連続的に行い得る、という利点を有する。それ故にそれ
らは、コーティングされた医薬品、特に医薬錠剤を生成
する連続方法の一部分として使用することができる。As already made clear, the methods described above have the advantage that they can be performed continuously. Therefore, they can be used as part of a continuous process for producing coated pharmaceuticals, especially pharmaceutical tablets.
従って本発明によれば、 回転プレスで医薬錠剤コアを連続的に形成する段階
と、 上記に定義された方法で錠剤コアを連続的にコーティ
ングする段階とを含む、コーティングされた錠剤を生成
する連続的な方法が得られる。Thus, according to the present invention, a continuous process for producing a coated tablet, comprising the steps of continuously forming a pharmaceutical tablet core on a rotary press, and continuously coating the tablet core in a manner as defined above. Method is obtained.
また本発明によれば、 前述した方法を実施するための装置であって、搬送装
置と、該搬送装置上に前記コアを給送する装置と、該搬
送装置が通過する領域にコーティング材料を供給するた
めの供給装置と、前記コーティング材料、前記搬送装
置、及び前記コアのうちの少なくとも1つを荷電して、
前記搬送装置が通過する領域に供給される前記コーティ
ング材料の電位を前記搬送装置上のコアの電位と異なる
ようにし、もって、前記コアの露出面に前記コーティン
グ材料が引き付けられて該露出面上にコーティングを形
成するようにした荷電装置とを含む装置において、 この装置が、乾燥粉末の形態でコーティング材料を供
給するための供給装置を含み、更に、前記コアに引き付
けられた乾燥粉末を前記コアに固着された融着フィルム
コーティングに転化するために、該乾燥粉末を処理する
装置を含むことを特徴とする装置が提供される。According to the present invention, there is also provided an apparatus for carrying out the above-described method, comprising: a transport device; a device for feeding the core onto the transport device; And supplying at least one of the coating material, the transport device, and the core,
The potential of the coating material supplied to the area where the transfer device passes is made different from the potential of the core on the transfer device, so that the coating material is attracted to the exposed surface of the core and is exposed on the exposed surface. A charging device adapted to form a coating, the device comprising: a supply device for supplying a coating material in the form of a dry powder, further comprising: supplying the dry powder attracted to the core to the core. An apparatus is provided that includes an apparatus for processing the dry powder for conversion to a fixed fused film coating.
この装置は更に回転プレスを含み得、この場合、前記
供給装置は前記プレスから前記搬送装置上へ前記コアを
供給するように作動する。The apparatus may further include a rotary press, wherein the feeding device is operative to feed the core from the press onto the transport device.
ここで、錠剤コアの静電コーティング方法および装置
を、添付図面につき、例として説明する。The method and apparatus for electrostatic coating of a tablet core will now be described by way of example with reference to the accompanying drawings.
第1図は、錠剤を一方の面についてコーティングする
装置の略側面図、 第2図は、第1図の装置を使用してコーティングされ
た錠剤を製造する連続プロセスのブロック図、 第3図は、コーティングされた錠剤の側面図、であ
る。FIG. 1 is a schematic side view of an apparatus for coating tablets on one side, FIG. 2 is a block diagram of a continuous process for producing coated tablets using the apparatus of FIG. 1, FIG. FIG. 2 is a side view of a coated tablet.
第1図に示す装置には、3組の遊びローラ2と、第1
図の矢印で示す方向に電動機4で駆動される駆動ローラ
3との回りを案内されるコンベヤ・ベルト1が包含され
ている。コンベヤ・ベルト1の大部分を囲んでブース5
が設けられている。The device shown in FIG.
It includes a conveyor belt 1 guided around a drive roller 3 driven by a motor 4 in the direction indicated by the arrow in the figure. Booth 5 around most of conveyor belt 1
Is provided.
ブース5の外側のコンベヤ・ベルト1の上流端部(第
1図で視て左端部)に錠剤コアを給送する装置が設けら
れているが、この図面には示されていない。上記装置の
形式は本発明の肝要な部分ではない。コンベヤ・ベルト
上方のブースの内部へ乾燥粉末を供給する給送装置6も
設けられている。図示された本発明の例においては、ガ
ン・バレル8の端部に取り付けられ、電圧供給源9に接
続された、単一の固定されたコロナ電極7を使用する静
電粉末ガンが給送装置6に含まれている。粉末と空気と
の混合物が、ベンチュリ粉末給送装置10からガン・バレ
ルへ給送される。A device for feeding tablet cores is provided at the upstream end (left end in FIG. 1) of the conveyor belt 1 outside the booth 5, but is not shown in this drawing. The type of device described above is not an integral part of the present invention. There is also provided a feeding device 6 for feeding the dry powder into the booth above the conveyor belt. In the example of the invention shown, an electrostatic powder gun using a single fixed corona electrode 7 attached to the end of a gun barrel 8 and connected to a voltage supply 9 comprises a feeding device. 6 are included. A mixture of powder and air is delivered from the Venturi powder feeder 10 to the gun barrel.
平面図が長方形で、コンベヤ・ベルト1の全幅および
その長さの一部分にわたって延びる電極11がブースの頂
部から懸垂されている。この電極11は電圧供給源12に接
続されている。アースに接続された別の長方形の電極18
が、電極11の下方の領域内において、コンベヤ・ベルト
1の真下でそれを支えている。コンベヤ・ベルト1は、
ポリ塩化ビニルとアルミニウムはくとの積層品で作ら
れ、アルミニウムはくはベルトの外層を形成し、ベルト
はアースに接続されている。Electrodes 11, which are rectangular in plan and extend over the entire width of the conveyor belt 1 and part of its length, are suspended from the top of the booth. This electrode 11 is connected to a voltage supply 12. Another rectangular electrode 18 connected to earth
Supports it under the conveyor belt 1 in the region below the electrode 11. Conveyor belt 1
Made from a laminate of polyvinyl chloride and aluminum foil, the aluminum foil forms the outer layer of the belt, and the belt is connected to ground.
コンベヤ・ベルトの下流端部の上に赤外線加熱器13お
よび振動プレート14が設けられている。Above the downstream end of the conveyor belt, an infrared heater 13 and a vibrating plate 14 are provided.
この装置の使用中、給送装置6により、ベルト1の上
流端部上に医薬錠剤コアが給送され、コアの一方の面を
ベルト上に載せ、他方を上方へ向け、コンベヤに沿って
通過する。錠剤コアへコーティングされる乾燥粉末は、
適当な電位(この例については粉末が正電位に荷電され
るものと仮定する)に粉末を荷電させるスプレー・ガン
によりブース5内へ吹き付けられる。ガンから吹き付け
られた粉末は、正電位に維持された電極11と、双方共ア
ースされたコンベヤ・ベルト1および電極18との間の領
域に入り込む。従って粉末は、電極11から離れてコンベ
ヤ・ベルト1および電極18に対し下方へ向けられる。従
ってコンベヤ・ベルトと、コンベヤ・ベルト上の錠剤コ
アとの上に粉末のコーティングが置かれる。During use of the device, the feeding device 6 feeds the pharmaceutical tablet core onto the upstream end of the belt 1 and places one side of the core on the belt, the other upward and passes along the conveyor. I do. The dry powder coated on the tablet core is
Blown into booth 5 by a spray gun that charges the powder to the appropriate potential (assuming that the powder is charged to a positive potential for this example). The powder sprayed from the gun enters the area between the electrode 11 maintained at a positive potential and the conveyor belt 1 and the electrode 18, both of which are grounded. The powder is thus directed away from the electrode 11 and downwards with respect to the conveyor belt 1 and the electrode 18. Thus, a powder coating is placed on the conveyor belt and the tablet cores on the conveyor belt.
次いで錠剤コアは、コーティングを溶融させて錠剤コ
アの上面の上にフィルム・コーティングを形成させるに
足りるだけ錠剤上の粉末のコーティングを加熱する赤外
線加熱器13の下を通される。錠剤が加熱器13の先へ運ば
れると、それらは、コーティングを均等化させる振動プ
レート14に接触される。The tablet core is then passed under an infrared heater 13 which heats the coating of the powder on the tablet enough to melt the coating and form a film coating on the upper surface of the tablet core. As the tablets are conveyed past the heater 13, they are contacted with a vibrating plate 14 which equalizes the coating.
錠剤コアの他面上に(若しそれが望ましければ)コー
ティングを施すために粉末が、第1図に示されたそれと
類似の、そのほかのコンベヤ装置上へ逆に載せられ、第
1図に関連して上述したプロセスが反復される。錠剤を
1つのコンベヤから別のコンベヤへ移動させ、且つ移動
中にそれらを裏返す装置は既に周知されている(例えば
英国特許明細書GB−1 075 404を参照のこと)。To apply a coating (if it is desired) on the other side of the tablet core, the powder is reversed onto another conveyor device similar to that shown in FIG. The process described above in connection with is repeated. Devices for transferring tablets from one conveyor to another and turning them over during the transfer are already known (see, for example, GB-1 075 404 GB).
ここで第2図につき説明する。丁度説明された装置お
よび寸法により、コーティングされた錠剤の連続生産が
得られることがわかるはずである。例えば高速回転プレ
スにより生成された錠剤コアは、第1図の装置へ直接に
給送され、そこでそれらの上面が、荷電された乾燥粉末
でコーティングされる。次いで乾燥粉末が加熱によって
溶融され、部分的にコーティングされた乾燥粉末は冷却
させられ、今度は、それらのコーティングされていない
面を最も上にして、第1図に示された種類の別の装置へ
給送される。それらのコーティングされていない面は、
荷電された乾燥粉末でコーティングされ、乾燥粉末コー
ティングは加熱によって溶融され、コーティングされた
錠剤は冷却させられ、次いで適宜の包装機械へ給送され
る。上記のプロセスは連続的に作動することができる。Referring now to FIG. It should be appreciated that the just described equipment and dimensions provide for continuous production of coated tablets. Tablet cores produced, for example, by a high speed rotary press are fed directly to the apparatus of FIG. 1, where their upper surfaces are coated with a charged dry powder. The dry powder is then melted by heating and the partially coated dry powder is allowed to cool, this time with another device of the type shown in FIG. 1 with their uncoated surfaces on top. Is sent to Those uncoated surfaces are
Coated with a charged dry powder, the dry powder coating is melted by heating, the coated tablets are allowed to cool, and then fed to a suitable packaging machine. The above process can operate continuously.
第3図には、上面15、下面16および円筒状側面17を有
する錠剤が示されている。第一コーティング段階におい
ては、面の一つ、例えば面15が完全にコーティングさ
れ、側壁17は、完全なコーティングではないが若干の粉
末コーティングを受ける。第二コーティング段階におい
ては、他方の面16が完全にコーティングされ、側壁17に
対するコーティングの残部が施される。FIG. 3 shows a tablet having an upper surface 15, a lower surface 16 and a cylindrical side surface 17. In the first coating stage, one of the faces, for example face 15, is completely coated, and the side walls 17 receive some but not a complete powder coating. In the second coating stage, the other side 16 is completely coated and the remaining coating on the side wall 17 is applied.
───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特公 昭38−17688(JP,B1) (58)調査した分野(Int.Cl.6,DB名) A61J 3/06 A61K 9/28 A61K 9/50 ────────────────────────────────────────────────── ─── Continued on the front page (56) References JP-B-38-17688 (JP, B1) (58) Fields investigated (Int. Cl. 6 , DB name) A61J 3/06 A61K 9/28 A61K 9 / 50
Claims (28)
と、 前記コアが前記搬送装置上で搬送される時に通過する領
域にコーティング材料を供給する段階と、 前記コアを前記コーティング材料とは異なる電位に維持
して、前記コアを前記領域を通って前記搬送装置上で搬
送し、それによって、前記コーティング材料が前記コア
の露出面に引き付けられて該露出面上にコーティングを
形成する段階と、 を含む医薬錠剤コアにコーティング材料をコーティング
する方法において、 前記コーティング材料として乾燥粉末を使用し、また、
該乾燥粉末が前記コアの露出面に引き付けられて該露出
面上にコーティングを形成した後に、この乾燥粉末が前
記コアに固着された融着フィルムコーティングに転化す
るように、この乾燥粉末を処理することを特徴とする方
法。A step of feeding a pharmaceutical tablet core onto a transport device; a step of supplying a coating material to an area through which the core passes as the core is transported over the transport device; Maintaining the core at a different potential and transporting the core through the area on the transport device, whereby the coating material is attracted to the exposed surface of the core to form a coating on the exposed surface A method of coating a pharmaceutical tablet core with a coating material, comprising: using a dry powder as the coating material;
After the dry powder is attracted to the exposed surface of the core to form a coating on the exposed surface, the dry powder is treated such that the dry powder is converted to a fused film coating adhered to the core. A method comprising:
その方法が連続プロセスとして行われるようにする方
法。2. The method according to claim 1, wherein
A method whereby the method is performed as a continuous process.
法において、 前記搬送段階において前記搬送装置に接触されていた前
記コアの面を露出させ且つ前記コアの融着フィルムコー
ティングを搬送装置に接触させて、当該搬送装置上に錠
剤コアを給送する段階と、 前記コアに被覆される乾燥粉末を当該搬送装置が通過す
る領域に供給する段階と 当該搬送装置又は前記コア、或いはそれら双方を前記乾
燥粉末とは異なった電位に維持して、前記コアを当該領
域を通って当該搬送装置上で搬送し、それによって、前
記乾燥粉末が前記コアの露出された面に引き付けられる
ようにする段階と、 新しく引き付けられた粉末が前記コアに固着された融着
フィルムコーティングに転化するように、この乾燥粉末
コーティングを処理する段階とを、更に後続する段階と
して含む方法。3. The method according to claim 1, wherein the surface of the core that has been in contact with the transfer device in the transfer step is exposed, and the fused film coating of the core is transferred. Contacting the device, feeding the tablet core onto the transport device, supplying the dry powder coated on the core to an area where the transport device passes, the transport device or the core, or the like. Maintaining both at a different potential than the dry powder and transporting the core through the area on the transport device such that the dry powder is attracted to the exposed surface of the core And treating this dry powder coating such that the newly attracted powder is converted to a fused film coating affixed to the core. Method to include as a continuation step.
第二コーティング段階中に使用される搬送装置が、第一
コーティング段階中に使用される搬送装置と異なるもの
である方法。4. The method according to claim 3, wherein
The method wherein the transport device used during the second coating stage is different from the transport device used during the first coating stage.
一つの項に記載の方法において、前記搬送装置がコンベ
ヤ・ベルトを含む方法。5. The method according to claim 1, wherein said transport device comprises a conveyor belt.
一つの項に記載の方法において、前記コアの表面上のコ
ーティングの深さを均等化するように、前記コーティン
グに更なる機械的処理を施すことを含む方法。6. A method according to any one of claims 1 to 5, wherein the coating is further added so as to equalize the depth of the coating on the surface of the core. A method comprising applying a mechanical treatment.
振動プレートまたは回転ローラの下に前記コアを通過さ
せることによって均等化段階が行われ、このプレート又
はローラが前記コア上のコーティングに接触してそれを
均等化する方法。7. The method according to claim 6, wherein
A method wherein the equalizing step is performed by passing the core under a vibrating plate or rotating roller, the plate or roller contacting and equalizing the coating on the core.
空気の噴流の下に前記コアを通過させることにより均等
化段階が行われる方法。8. The method according to claim 6, wherein:
The method wherein the equalization step is performed by passing the core under a jet of air.
一つの項に記載の方法において、加熱により、前記乾燥
粉末コーティングが融着フィルムへ転化される方法。9. The method according to claim 1, wherein the dry powder coating is converted to a fused film by heating.
か一つの項に記載の方法において、前記粉末が荷電され
る方法。10. The method according to any one of claims 1 to 9, wherein the powder is charged.
て、前記搬送装置が通過する領域へ前記粉末が供給され
る際にそれが荷電される方法。11. The method according to claim 10, wherein the powder is charged as it is supplied to the area through which the transport device passes.
方法において、コロナ荷電装置を用いて荷電が行われる
方法。12. The method according to claim 10, wherein charging is performed using a corona charging device.
か一つの項に記載の方法において、選定された電位に維
持された1組以上の電極が、前記搬送装置上方の、前記
粉末が供給される領域に設けられる方法。13. The method according to any one of claims 1 to 12, wherein one or more sets of electrodes maintained at a selected potential are arranged above said transport device. A method provided in the area where the powder is supplied.
か一つの項に記載の方法において、前記粉末が、1μm
から1000μmまでの範囲の粒径を有する方法。14. The method according to any one of claims 1 to 13, wherein the powder is 1 μm
A method having a particle size in the range from to 1000 μm.
か一つの項に記載の方法において、前記粉末が、106か
ら1024Ωmの範囲の比較的に高い抵抗率を有する方法。15. The method according to claim 1, wherein the powder has a relatively high resistivity in the range of 10 6 to 10 24 Ωm. .
か一つの項に記載の方法において、前記粉末が、液相に
おける場合、500Pas未満の粘度を有する方法。16. The method according to claim 1, wherein said powder has a viscosity of less than 500 Pas when in the liquid phase.
か一つの項に記載の方法において、前記粉末が、固相へ
の復帰後に、0.5N/m2を超える引張強さを有する方法。17. The method according to any one of claims 1 to 16, wherein the powder has a tensile strength of more than 0.5 N / m 2 after returning to the solid phase. How to have.
か一つの項に記載の方法において、前記粉末が、50℃か
ら180℃までの範囲にある融点を有する方法。18. The method according to any one of claims 1 to 17, wherein the powder has a melting point in the range from 50 ° C to 180 ° C.
て、前記粉末が、60℃から100℃までの範囲にある融点
を有する方法。19. The method according to claim 18, wherein said powder has a melting point in the range from 60 ° C. to 100 ° C.
か一つの項に記載の方法において、前記乾燥粉末が全
く、または概ね、ポリアミド、ポリアルキン、ワック
ス、油、ポリエステル、ポリオキシエチレン、糖、糖ア
ルコールおよびエチレン酢酸ビニル共重合体を含むグル
ープ内の1種以上の材料から成る方法。20. The method according to any one of claims 1 to 19, wherein said dry powder is completely or substantially polyamide, polyalkyne, wax, oil, polyester, polyoxyethylene. A process comprising one or more materials in the group comprising: a sugar, a sugar alcohol, and an ethylene vinyl acetate copolymer.
て、前記乾燥粉末が全く、または概ね、キシリトールか
ら成る方法。21. The method of claim 20, wherein said dry powder consists entirely or substantially of xylitol.
て、前記乾燥粉末が全く、または概ね、ポリカプロラク
トンから成る方法。22. The method according to claim 20, wherein said dry powder consists entirely or substantially of polycaprolactone.
か一つの項に記載の方法において、前記粉末を付与する
前に前記錠剤コアの電導性を増大させるために該錠剤コ
アを処理する方法。23. The method according to any one of claims 1 to 22, wherein the tablet core is added to increase the electrical conductivity of the tablet core before applying the powder. How to handle.
前記処理が前記錠剤コアの外部を湿らせることを含む方
法。24. The method according to claim 23, wherein:
The method wherein the treatment comprises wetting the exterior of the tablet core.
する方法であって、 回転プレス上で連続して医薬錠剤コアを形成する段階
と、 請求の範囲第1項から第24項までの何れか一つの項に記
載の方法によって連続して前記錠剤コアをコーティング
する段階とを含む方法。25. A method for continuously producing coated tablets, comprising the steps of: forming a continuous pharmaceutical tablet core on a rotary press; and any one of claims 1 to 24. Coating the tablet core continuously according to the method of one of the preceding paragraphs.
れか一つの項に記載の方法を実施するための装置であっ
て、搬送装置と、該搬送装置上に前記コアを給送する装
置と、該搬送装置が通過する領域にコーティング材料を
供給するための供給装置と、前記コーティング材料、前
記搬送装置、及び前記コアのうちの少なくとも1つを荷
電して、前記搬送装置が通過する領域に供給される前記
コーティング材料の電位を前記搬送装置上のコアの電位
と異なるようにし、もって、前記コアの露出面に前記コ
ーティング材料が引き付けられて該露出面上にコーティ
ングを形成するようにした荷電装置とを含む装置におい
て、 この装置が、乾燥粉末の形態でコーティング材料を供給
するための供給装置を含み、更に、前記コアに引き付け
られた乾燥粉末を前記コアに固着された融着フィルムコ
ーティングに転化するために、該乾燥粉末を処理する装
置を含むことを特徴とする装置。26. An apparatus for carrying out the method according to any one of claims 1 to 24, comprising: a transport device; and feeding the core onto the transport device. A coating device, a supply device for supplying a coating material to an area where the transfer device passes, and charging at least one of the coating material, the transfer device, and the core so that the transfer device passes therethrough. The potential of the coating material supplied to the area to be applied is different from the potential of the core on the transport device, such that the coating material is attracted to the exposed surface of the core to form a coating on the exposed surface. A charging device, comprising: a supply device for supplying a coating material in the form of a dry powder; and further comprising a dry powder attracted to said core. To convert the anchored fusion film coating on the core, device characterized in that it comprises a device for processing the dried powder.
て、更に回転プレスを含み、前記供給装置が前記回転プ
レスから前記搬送装置上へ前記コアを供給するように作
動する装置。27. The apparatus according to claim 26, further comprising a rotary press, wherein said supply device is operable to supply said core from said rotary press onto said transport device.
装置において、前記搬送装置は傾斜した静止表面を含む
装置。28. Apparatus according to claim 26 or claim 27, wherein the transport device comprises an inclined stationary surface.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9103711.9 | 1991-02-22 | ||
GB9103711A GB2253164B (en) | 1991-02-22 | 1991-02-22 | Improvements in or relating to electrostatic coating of substrates of medicinal products |
PCT/GB1992/000323 WO1992014451A1 (en) | 1991-02-22 | 1992-02-21 | Improvements in or relating to electrostatic coating of substrates of medicinal products |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05508337A JPH05508337A (en) | 1993-11-25 |
JP2919971B2 true JP2919971B2 (en) | 1999-07-19 |
Family
ID=10690391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4504620A Expired - Fee Related JP2919971B2 (en) | 1991-02-22 | 1992-02-21 | Method for coating a pharmaceutical tablet core with a coating material and apparatus for performing the method |
Country Status (15)
Country | Link |
---|---|
US (2) | US5470603A (en) |
EP (1) | EP0526606B1 (en) |
JP (1) | JP2919971B2 (en) |
AT (1) | ATE126431T1 (en) |
AU (1) | AU653989B2 (en) |
CA (1) | CA2081921C (en) |
CZ (1) | CZ343492A3 (en) |
DE (1) | DE69204127T2 (en) |
DK (1) | DK0526606T3 (en) |
ES (1) | ES2078036T3 (en) |
GB (1) | GB2253164B (en) |
GR (1) | GR3018080T3 (en) |
HU (1) | HU215907B (en) |
PL (1) | PL166928B1 (en) |
WO (1) | WO1992014451A1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007524478A (en) * | 2003-12-30 | 2007-08-30 | フォウカス ファーマスーティカルズ リミティド | Method and apparatus for spraying powdered material onto a substrate |
US7390524B1 (en) | 2004-05-20 | 2008-06-24 | Advanced Cardiovascular Systems, Inc. | Method for electrostatic spraying of an abluminal stent surface |
US7867547B2 (en) | 2005-12-19 | 2011-01-11 | Advanced Cardiovascular Systems, Inc. | Selectively coating luminal surfaces of stents |
US8003156B2 (en) | 2006-05-04 | 2011-08-23 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
US8017237B2 (en) | 2006-06-23 | 2011-09-13 | Abbott Cardiovascular Systems, Inc. | Nanoshells on polymers |
US8048448B2 (en) | 2006-06-15 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Nanoshells for drug delivery |
US8048441B2 (en) | 2007-06-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Nanobead releasing medical devices |
US8097292B2 (en) | 2004-04-27 | 2012-01-17 | Advanced Cardiovascular Systems, Inc, | Methods for electrostatic coating of an abluminal stent surface |
US8197879B2 (en) | 2003-09-30 | 2012-06-12 | Advanced Cardiovascular Systems, Inc. | Method for selectively coating surfaces of a stent |
US8603530B2 (en) | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
Families Citing this family (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU680019B2 (en) * | 1993-08-30 | 1997-07-17 | Warner-Lambert Company Llc | Tablet coating based on a melt-spun mixture of a saccharide and apolymer |
US5567238A (en) * | 1994-12-06 | 1996-10-22 | Coating Machinery Systems, Inc. | Oscillating bed seed coating machine for particulate material |
US7008668B2 (en) | 1995-05-09 | 2006-03-07 | Phoqus Pharmaceuticals Limited | Powder coating composition for electrostatic coating of pharmaceutical substrates |
ATE293440T1 (en) * | 1995-05-09 | 2005-05-15 | Phoqus Pharmaceuticals Ltd | POWDER COATING COMPOSITION FOR ELECTROSTATIC COATING OF PHARMACEUTICAL SUBSTRATES |
GB2316342B (en) * | 1995-05-09 | 2000-01-12 | Colorcon Ltd | Electrostatic coating |
GB2333975B (en) * | 1995-05-09 | 2000-01-12 | Colorcon Ltd | Improvements in or relating to electrostatic coating of substrates |
US5714007A (en) | 1995-06-06 | 1998-02-03 | David Sarnoff Research Center, Inc. | Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate |
SE505906C2 (en) * | 1996-02-19 | 1997-10-20 | Hanian Hb | Electrostatic coating of small, non-grounded objects |
US5861191A (en) * | 1996-02-26 | 1999-01-19 | Technology Licensing Company | Bacteriostatic coating of polymeric conduit |
DE19758730B4 (en) * | 1996-04-09 | 2004-03-04 | Delsys Pharmaceutical Corp. | Electrostatic chuck for manufacturing pharmaceutical products e.g. tablets, inhaler substrate |
US5858099A (en) * | 1996-04-09 | 1999-01-12 | Sarnoff Corporation | Electrostatic chucks and a particle deposition apparatus therefor |
FI111816B (en) * | 1996-09-19 | 2003-09-30 | Metso Paper Inc | A method and apparatus for transferring additional material to the surface of a moving web of material |
GB9623634D0 (en) | 1996-11-13 | 1997-01-08 | Bpsi Holdings Inc | Method and apparatus for the coating of substrates for pharmaceutical use |
US6004752A (en) * | 1997-07-29 | 1999-12-21 | Sarnoff Corporation | Solid support with attached molecules |
US6045753A (en) * | 1997-07-29 | 2000-04-04 | Sarnoff Corporation | Deposited reagents for chemical processes |
GB9720061D0 (en) | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
US6395345B1 (en) | 1997-11-13 | 2002-05-28 | Soerensen Frede | Coating material and application methods therefor |
US6974598B2 (en) | 1999-05-14 | 2005-12-13 | Coors Worldwide Inc. | Method of cooling a beverage |
CO5070568A1 (en) * | 1998-05-22 | 2001-08-28 | Eurand Internatrional Spa | LAYER AND APPLIANCE APPLICATION PROCESS FOR EFFECT |
JP2935697B1 (en) * | 1998-07-01 | 1999-08-16 | 勲 菅井 | Substrate coating method |
US6652903B2 (en) | 1998-07-09 | 2003-11-25 | Lts Lohmann Therapie-Systeme Ag | Dry-copying method for producing flat, individually dosed preparations of active agents |
DE19830650C1 (en) * | 1998-07-09 | 1999-08-12 | Lohmann Therapie Syst Lts | Dry copying to give bonded active ingredients at a substrate surface for transdermal therapy |
US6146685A (en) * | 1998-11-05 | 2000-11-14 | Delsys Pharmaceutical Corporation | Method of deposition a dry powder and dispensing device |
US6120832A (en) * | 1998-11-25 | 2000-09-19 | The Lubrizol Corporation | Method and apparatus for measuring the transfer efficiency of a coating material |
US6372246B1 (en) | 1998-12-16 | 2002-04-16 | Ortho-Mcneil Pharmaceutical, Inc. | Polyethylene glycol coating for electrostatic dry deposition of pharmaceuticals |
US6432448B1 (en) | 1999-02-08 | 2002-08-13 | Fmc Corporation | Edible coating composition |
US6723342B1 (en) | 1999-02-08 | 2004-04-20 | Fmc Corporation | Edible coating composition |
US6923979B2 (en) * | 1999-04-27 | 2005-08-02 | Microdose Technologies, Inc. | Method for depositing particles onto a substrate using an alternating electric field |
US6500462B1 (en) | 1999-10-29 | 2002-12-31 | Fmc Corporation | Edible MCC/PGA coating composition |
GB9929946D0 (en) * | 1999-12-17 | 2000-02-09 | Phoqus Limited | Electrostatic application of powder material to solid dosage forms |
US6806017B2 (en) | 1999-12-17 | 2004-10-19 | Phoqus Limited | Electrostatic application of powder material to solid dosage forms |
GB0002305D0 (en) | 2000-02-01 | 2000-03-22 | Phoqus Limited | Power material for electrostatic application |
JP2004502724A (en) * | 2000-07-06 | 2004-01-29 | デルシス ファーマシューティカル コーポレイション | Formulation of healthcare products with increased stability |
TR200300731T2 (en) | 2000-11-28 | 2004-08-23 | Fmc Corporation | Composition of edible PGA coating |
GB2370243B (en) * | 2000-12-21 | 2004-06-16 | Phoqus Ltd | Electrostatic application of powder material to solid dosage forms in an elect ric field |
US6511541B2 (en) | 2001-02-27 | 2003-01-28 | Spray Dynamics, Ltd. | Powder applicator for particulate material coating |
GB0117619D0 (en) * | 2001-07-19 | 2001-09-12 | Phoqus Ltd | Pharmaceutical dosage form |
GB0117618D0 (en) * | 2001-07-19 | 2001-09-12 | Phoqus Ltd | Pharmaceutical dosage form |
GB0204772D0 (en) * | 2002-02-28 | 2002-04-17 | Phoqus Ltd | Pharmaceutical dosage forms |
GB2402895B (en) * | 2003-06-18 | 2006-08-23 | Phoqus Pharmaceuticals Ltd | Method and apparatus for the application of powder material to substrates |
GB0318353D0 (en) * | 2003-08-05 | 2003-09-10 | Phoqus Pharmaceuticals Ltd | Coating of surgical devices |
US6907913B1 (en) | 2003-11-12 | 2005-06-21 | C & J Industries, Inc. | Tire mounting device and method |
GB0407312D0 (en) * | 2004-03-31 | 2004-05-05 | Phoqus Pharmaceuticals Ltd | Method and apparatus for the application of powder material to substrates |
TWI428271B (en) * | 2004-06-09 | 2014-03-01 | Smithkline Beecham Corp | Apparatus and method for pharmaceutical production |
US8101244B2 (en) * | 2004-06-09 | 2012-01-24 | Smithkline Beecham Corporation | Apparatus and method for producing or processing a product or sample |
US7205027B2 (en) * | 2004-09-27 | 2007-04-17 | Brandyn Brosemer | Powder coating method providing enhanced finish characteristics |
US20090062909A1 (en) | 2005-07-15 | 2009-03-05 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
CN105233349B (en) | 2005-07-15 | 2019-06-18 | 胶束技术股份有限公司 | The polymer coating of drug powder comprising controlled morphology |
EP1912614A4 (en) * | 2005-08-03 | 2009-08-05 | Univ Western Ontario | Direct coating solid dosage forms using powdered materials |
MY157620A (en) * | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
CA2650590C (en) | 2006-04-26 | 2018-04-03 | Micell Technologies, Inc. | Coatings containing multiple drugs |
AU2007249341B2 (en) | 2006-05-12 | 2012-02-02 | Mars, Incorporated | Use of powders for creating images on objects, webs or sheets |
US7976872B2 (en) * | 2006-07-24 | 2011-07-12 | L. Perrigo Company | Method for distributing a pharmaceutically active compound in an excipient |
WO2008042909A2 (en) | 2006-10-02 | 2008-04-10 | Micell Technologies Inc. | Surgical sutures having increased strength |
CA2667228C (en) | 2006-10-23 | 2015-07-14 | Micell Technologies, Inc. | Holder for electrically charging a substrate during coating |
CN101711137B (en) | 2007-01-08 | 2014-10-22 | 米歇尔技术公司 | Stents having biodegradable layers |
US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
EP2138166A4 (en) * | 2007-04-26 | 2012-11-21 | Eisai R&D Man Co Ltd | Process for production of tablet |
JP2010527746A (en) | 2007-05-25 | 2010-08-19 | ミセル テクノロジーズ、インコーポレイテッド | Polymer film for medical device coating |
GB0714670D0 (en) * | 2007-07-27 | 2007-09-05 | Ineos Healthcare Ltd | Use |
GB0720220D0 (en) * | 2007-10-16 | 2007-11-28 | Ineos Healthcare Ltd | Compound |
CN102083397B (en) | 2008-04-17 | 2013-12-25 | 米歇尔技术公司 | Stents having bioabsorbable layers |
WO2010009335A1 (en) | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug delivery medical device |
US8834913B2 (en) | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
EP2411083A4 (en) | 2009-03-23 | 2013-11-13 | Micell Technologies Inc | Drug delivery medical device |
WO2010120552A2 (en) | 2009-04-01 | 2010-10-21 | Micell Technologies, Inc. | Coated stents |
EP3366326A1 (en) | 2009-04-17 | 2018-08-29 | Micell Technologies, Inc. | Stents having controlled elution |
EP2453834A4 (en) | 2009-07-16 | 2014-04-16 | Micell Technologies Inc | Drug delivery medical device |
GB0913525D0 (en) | 2009-08-03 | 2009-09-16 | Ineos Healthcare Ltd | Method |
WO2011097103A1 (en) | 2010-02-02 | 2011-08-11 | Micell Technologies, Inc. | Stent and stent delivery system with improved deliverability |
GB201001779D0 (en) | 2010-02-04 | 2010-03-24 | Ineos Healthcare Ltd | Composition |
US8795762B2 (en) | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
CA2797110C (en) | 2010-04-22 | 2020-07-21 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
CA2805631C (en) | 2010-07-16 | 2018-07-31 | Micell Technologies, Inc. | Drug delivery medical device |
US9636309B2 (en) | 2010-09-09 | 2017-05-02 | Micell Technologies, Inc. | Macrolide dosage forms |
US20120177742A1 (en) | 2010-12-30 | 2012-07-12 | Micell Technologies, Inc. | Nanoparticle and surface-modified particulate coatings, coated balloons, and methods therefore |
US10464100B2 (en) | 2011-05-31 | 2019-11-05 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
US10117972B2 (en) | 2011-07-15 | 2018-11-06 | Micell Technologies, Inc. | Drug delivery medical device |
AU2012326010B2 (en) | 2011-10-18 | 2017-05-11 | Micell Technologies, Inc. | Drug delivery medical device |
US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
KR20150143476A (en) | 2013-03-12 | 2015-12-23 | 미셀 테크놀로지즈, 인코포레이티드 | Bioabsorbable biomedical implants |
WO2014186532A1 (en) | 2013-05-15 | 2014-11-20 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
CN106944292A (en) * | 2017-02-20 | 2017-07-14 | 陈婷 | A kind of precision part paint spraying machine of anti-lost paint |
CN107028765A (en) * | 2017-05-05 | 2017-08-11 | 盐城卫生职业技术学院 | Pharmaceutical process plant and drug handling device |
CN113600386B (en) * | 2021-09-02 | 2022-11-01 | 滁州学院 | Coating spraying equipment for civil engineering construction professional decorative plates |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US50097A (en) * | 1865-09-26 | Improved machine for making drain-tiles | ||
BE522840A (en) * | ||||
US1226824A (en) * | 1916-10-30 | 1917-05-22 | Dale G Steely | Method and apparatus for coating chocolates. |
US2421801A (en) * | 1941-09-22 | 1947-06-10 | Gromiller Inc | Apparatus for fusing the coating on tablets |
US2555519A (en) * | 1947-03-11 | 1951-06-05 | Gen Motors Corp | Method of painting electrostatically nonconducting articles |
US2685537A (en) * | 1948-03-05 | 1954-08-03 | Dunmire Russell Paul | Apparatus for the coating of pellets |
NL294399A (en) * | 1962-06-22 | |||
NL6406815A (en) * | 1963-06-19 | 1964-12-21 | ||
GB1123517A (en) * | 1967-04-10 | 1968-08-14 | Samuel Phillip Lipoma | Method and apparatus for applying a particulate material to a food product |
US3536034A (en) * | 1968-01-29 | 1970-10-27 | Dawn Donut Co Inc | Apparatus for coating edibles |
GB1449993A (en) * | 1973-10-01 | 1976-09-15 | American Can Co | Method and apparatus for distributing plastics on an irregular wokpiece surface |
US4209550A (en) * | 1976-01-19 | 1980-06-24 | Xerox Corporation | Coating carrier materials by electrostatic process |
DE2636152C2 (en) * | 1976-08-11 | 1980-11-06 | Arcana Chem.-Pharm. Fabrik Gmbh, Spittal, Drau (Oesterreich) | Process for the production of coated tablets |
FR2447794A1 (en) * | 1979-02-05 | 1980-08-29 | Valentine Cie Vernis | PROCESS FOR COATING THERMOSETTING PLASTIC MATERIALS AND PRODUCTS OBTAINED ACCORDING TO THIS PROCESS |
GB2056885A (en) * | 1979-08-08 | 1981-03-25 | Blundell Permoglaze Ltd | Powder coating cellulose fibre substrates |
JPS6045806B2 (en) * | 1979-08-22 | 1985-10-12 | 株式会社日立製作所 | Air flow meter using heating resistor |
IT1149716B (en) * | 1982-02-02 | 1986-12-10 | Edt Spa | PROCEDURE AND APPARATUS FOR THE ELECTROSTATIC APPLICATION OF LIQUIDS OR POWDERS ON SUBSTANCES AND OBJECTS |
US4495217A (en) * | 1982-04-19 | 1985-01-22 | Schrum Timothy J | Method for applying powdered coatings |
GB8314025D0 (en) * | 1983-05-20 | 1983-06-29 | Pharmaindev Ltd | Electrostatic coating of materials |
IT1163548B (en) * | 1983-06-21 | 1987-04-08 | Pirelli Cavi Spa | MULTI-POLE CABLE WITH FLUID OIL |
GB8400562D0 (en) * | 1984-01-10 | 1984-02-15 | Pharmindey Ltd | Electrostatic coating materials |
DE3500988C1 (en) * | 1985-01-09 | 1986-02-13 | Roland 6231 Schwalbach Sommer | Probe for measuring gaseous or liquid flows with respect to direction and strength |
JPH0675692B2 (en) * | 1985-05-16 | 1994-09-28 | 小野田セメント株式会社 | Electrostatic powder coating method and coating equipment |
GB8514915D0 (en) * | 1985-06-12 | 1985-07-17 | Vincent Processes Ltd | Coating apparatus |
US4774102A (en) * | 1986-06-09 | 1988-09-27 | Morton Thiokol, Inc. | Method of electrostatic powder spray coating |
EP0265376A1 (en) * | 1986-10-01 | 1988-04-27 | Ciba-Geigy Ag | Coating of small objects |
SE463541B (en) * | 1987-08-31 | 1990-12-10 | Lejus Medical Ab | GRANULATED PRODUCT TRANSFER OF A MELT OF ITSELF AND THE PROCEDURE FOR ITS PREPARATION |
GB8819002D0 (en) * | 1988-08-10 | 1988-09-14 | Johnson H C | Coating apparatus |
DE3839440C1 (en) * | 1988-11-23 | 1989-11-23 | Sollich Gmbh & Co Kg, 4902 Bad Salzuflen, De | |
DE3903235A1 (en) * | 1989-02-03 | 1990-08-09 | Hoechst Ag | METHOD AND DEVICE FOR THE SURFACE PRE-TREATMENT OF SURFACE BODIES WITH ELECTRIC CORONA DISCHARGE |
US5000978A (en) * | 1989-06-29 | 1991-03-19 | The Procter & Gamble Company | Electrostatic coating of detergent granules |
US5178874A (en) * | 1989-06-30 | 1993-01-12 | Smithkline Beechman Corporation | Intermittent release dosage form |
US5132142A (en) * | 1991-03-19 | 1992-07-21 | Glatt Gmbh | Apparatus and method for producing pellets by layering power onto particles |
-
1991
- 1991-02-22 GB GB9103711A patent/GB2253164B/en not_active Expired - Fee Related
-
1992
- 1992-02-21 CA CA002081921A patent/CA2081921C/en not_active Expired - Lifetime
- 1992-02-21 JP JP4504620A patent/JP2919971B2/en not_active Expired - Fee Related
- 1992-02-21 AT AT92905114T patent/ATE126431T1/en not_active IP Right Cessation
- 1992-02-21 HU HU9203652A patent/HU215907B/en unknown
- 1992-02-21 AU AU12084/92A patent/AU653989B2/en not_active Expired
- 1992-02-21 US US07/937,870 patent/US5470603A/en not_active Expired - Lifetime
- 1992-02-21 DE DE69204127T patent/DE69204127T2/en not_active Expired - Lifetime
- 1992-02-21 ES ES92905114T patent/ES2078036T3/en not_active Expired - Lifetime
- 1992-02-21 PL PL92296624A patent/PL166928B1/en not_active IP Right Cessation
- 1992-02-21 WO PCT/GB1992/000323 patent/WO1992014451A1/en not_active Application Discontinuation
- 1992-02-21 EP EP92905114A patent/EP0526606B1/en not_active Expired - Lifetime
- 1992-02-21 DK DK92905114.2T patent/DK0526606T3/en active
- 1992-11-19 CZ CS923434A patent/CZ343492A3/en unknown
-
1995
- 1995-08-15 US US08/515,210 patent/US5656080A/en not_active Expired - Lifetime
- 1995-11-15 GR GR950403198T patent/GR3018080T3/en unknown
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8197879B2 (en) | 2003-09-30 | 2012-06-12 | Advanced Cardiovascular Systems, Inc. | Method for selectively coating surfaces of a stent |
JP2007524478A (en) * | 2003-12-30 | 2007-08-30 | フォウカス ファーマスーティカルズ リミティド | Method and apparatus for spraying powdered material onto a substrate |
US8097292B2 (en) | 2004-04-27 | 2012-01-17 | Advanced Cardiovascular Systems, Inc, | Methods for electrostatic coating of an abluminal stent surface |
US7390524B1 (en) | 2004-05-20 | 2008-06-24 | Advanced Cardiovascular Systems, Inc. | Method for electrostatic spraying of an abluminal stent surface |
US7867547B2 (en) | 2005-12-19 | 2011-01-11 | Advanced Cardiovascular Systems, Inc. | Selectively coating luminal surfaces of stents |
US8596215B2 (en) | 2006-05-04 | 2013-12-03 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
US8465789B2 (en) | 2006-05-04 | 2013-06-18 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
US8003156B2 (en) | 2006-05-04 | 2011-08-23 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
US8637110B2 (en) | 2006-05-04 | 2014-01-28 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
US8741379B2 (en) | 2006-05-04 | 2014-06-03 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
US8603530B2 (en) | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
US8808342B2 (en) | 2006-06-14 | 2014-08-19 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
US8048448B2 (en) | 2006-06-15 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Nanoshells for drug delivery |
US8017237B2 (en) | 2006-06-23 | 2011-09-13 | Abbott Cardiovascular Systems, Inc. | Nanoshells on polymers |
US8293367B2 (en) | 2006-06-23 | 2012-10-23 | Advanced Cardiovascular Systems, Inc. | Nanoshells on polymers |
US8592036B2 (en) | 2006-06-23 | 2013-11-26 | Abbott Cardiovascular Systems Inc. | Nanoshells on polymers |
US8048441B2 (en) | 2007-06-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Nanobead releasing medical devices |
Also Published As
Publication number | Publication date |
---|---|
US5656080A (en) | 1997-08-12 |
GB2253164A (en) | 1992-09-02 |
EP0526606A1 (en) | 1993-02-10 |
JPH05508337A (en) | 1993-11-25 |
HU215907B (en) | 1999-03-29 |
CZ343492A3 (en) | 1993-08-11 |
PL296624A1 (en) | 1993-11-02 |
DE69204127D1 (en) | 1995-09-21 |
GB9103711D0 (en) | 1991-04-10 |
HU9203652D0 (en) | 1994-04-28 |
GR3018080T3 (en) | 1996-02-29 |
CA2081921A1 (en) | 1992-08-23 |
AU653989B2 (en) | 1994-10-20 |
GB2253164B (en) | 1994-10-05 |
DK0526606T3 (en) | 1995-12-27 |
DE69204127T2 (en) | 1996-04-04 |
ATE126431T1 (en) | 1995-09-15 |
EP0526606B1 (en) | 1995-08-16 |
WO1992014451A1 (en) | 1992-09-03 |
AU1208492A (en) | 1992-09-15 |
US5470603A (en) | 1995-11-28 |
HUT66848A (en) | 1995-01-30 |
PL166928B1 (en) | 1995-07-31 |
CA2081921C (en) | 2004-01-27 |
ES2078036T3 (en) | 1995-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2919971B2 (en) | Method for coating a pharmaceutical tablet core with a coating material and apparatus for performing the method | |
US7862848B2 (en) | Direct coating solid dosage forms using powdered materials | |
EP0869847B1 (en) | Electrostatic coating | |
US7153538B2 (en) | Method and apparatus for the coating of substrates for pharmaceutical use | |
EP1343592B1 (en) | Electrostatic application of powder material to solid dosage forms in an electric field | |
EP0881953B1 (en) | Electrostatic coating of small falling objects | |
JP2642634B2 (en) | Powder lamination method | |
CA2220485C (en) | Electrostatic coating | |
CA2246790A1 (en) | Electrostatic coating of small falling objects |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |